Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Eli Lilly And Co

Recent news which mentions Eli Lilly And Co

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Healthy Returns: Eli Lilly’s chief scientific officer breaks down the latest obesity pill data
Tags Social issues UnitedHealth Group Inc Healthy Returns
From CNBC.com News
Trump fires Fed's Cook, Musk sues Apple and OpenAI, Netflix's theatrical run and more in Morning Squawk
Tags Economy Investment strategy Technology
From CNBC.com News
Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval
Tags Pharmaceuticals Health care industry Biotechnology
From CNBC.com News
A world on weight loss drugs: How GLP-1s are reshaping the economy
Tags Nestle SA Travel Zealand Pharma A/S
From CNBC.com News
Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors
Tags Structure Therapeutics Inc CVS Health Corp Business
From CNBC.com News
CNBC's UK Exchange newsletter: The price is REIT
Tags CNBC UK Exchange Eli Lilly and Co Perella Weinberg Partners
From CNBC.com News
FDA approves first-ever glucose monitoring system for weight loss from Signos
Tags Pharmaceuticals Health care industry Biotechnology
From CNBC.com News
Viking Therapeutics shares fall more than 30% on disappointing obesity pill trial data
Tags Companies Business US: News
From CNBC.com News
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
Tags Eli Lilly and Co Health & Science Biotech and Pharmaceuticals
From CNBC.com News
'Don't quit the market' when it's frothy, says Jim Cramer. Here's why
Tags Markets Circle Internet Group Inc Investing
From CNBC.com News
Eli Lilly hikes price of diabetes drug Mounjaro in UK as Trump pressures pharma to align drug costs
Tags Eli Lilly and Co Biotech and Pharmaceuticals Health & Science
From CNBC.com News
Cramer's Lightning Round: Affirm is a buy
Tags stocks Investing S&P 500
From CNBC.com News
5 things to know before the Thursday open: Chip tariffs | Cook's White House visit | Wall Street's fashionista
Tags Jack in the Box Inc Investing Markets
From CNBC.com News
Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar
Tags Business News Breaking News: Business Health care industry
From CNBC.com News
Eli Lilly's obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for approval
Tags Eli Lilly and Co Health & Science Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Medicare, Medicaid will reportedly pilot covering obesity drugs – a potential win for drugmakers
Tags Roche Holding AG Healthy Returns Social issues
From CNBC.com News
5 things to know before the Monday open: Berkshire's tariff fears | Ethereum turns 10 | Restaurants embrace spicy
Tags Advanced Micro Devices Inc Robinhood Markets Inc Business
From CNBC.com News
Cramer's week ahead: Earnings from Palantir, Berkshire Hathaway, Disney and McDonald's
Tags McDonald's Corp Stock markets Mad Money
From CNBC.com News
Trump's drug price ultimatum sets pharma firms scrambling
Tags AbbVie Inc AstraZeneca PLC Eli Lilly and Co
From CNBC.com News
Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity
Tags Pharmaceuticals Health care industry Novo Nordisk A/S
From CNBC.com News
Trump's pharmaceutical tariffs could affect some drugmakers more than others
Tags Bristol/Myers Squibb Co GSK plc Health care industry
From CNBC.com News
Weight loss drugs could be a gamechanger for women with a common hormonal disorder
Tags Health care industry Biotechnology Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound
Tags Eli Lilly and Co Novo Nordisk A/S Health care industry
From CNBC.com News
Cramer's Lightning Round: Rocket Lab is a buy
Tags Rocket Lab USA Inc stocks Investing
From CNBC.com News
Trump's 200% tariff threat leaves pharma firms scrambling with scenario planning
Tags Pharmaceuticals Biotechnology US: News
From CNBC.com News
Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses
Tags Health & Science Biotech and Pharmaceuticals Eli Lilly and Co
From CNBC.com News
Trump threatens to put up to 200% tariff on pharmaceuticals 'very soon'
Tags Companies Business US: News
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags Red Robin Gourmet Burgers Inc Chevron Corp Halliburton Co
From CNBC.com News
Port strike fallout: Blockbuster weight-loss drug supply from Wegovy to Ozempic, Mounjaro, Zepbound caught up in East Coast trade shutdown
Tags Labor unions Economy Novo Nordisk A/S
From CNBC.com News
East and Gulf Coast ports strike, with ILA longshoremen walking off job, stranding billions in trade
Tags Novo Nordisk A/S Samsung Electronics Co Ltd Walmart Inc
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.